What does CUSIP 98987D102 represent in this 13F holders report?

CUSIP 98987D102 is the security identifier for ZVSA - ZYVERSA THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held ZVSA - ZYVERSA THERAPEUTICS INC - COM in Q1 2023?

6 institutional investors reported ZVSA - ZYVERSA THERAPEUTICS INC - COM for Q1 2023. Use the holders table for investor-level position and value details.

ZYVERSA THERAPEUTICS INC - COM (ZVSA)

CUSIP: 98987D102

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM
Total 13F shares: 141,699
Total 13F value: $273,479
Share change: +62,793
SEC-reported price per share: $1.93
Number of holders: 6
Value change: +$126,464
Number of buys: 6
Number of sells: 1

Security key

98987D102

Report period

Q1 2023

Institutions

Top holders

ZVSA full security history Ownership snapshot Full 13F holder table ZyVersa Therapeutics, Inc. SEC filings ZyVersa Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ZVSA - ZYVERSA THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Daniel J. O'Connor

Disclosed value leader

GOLDMAN SACHS GROUP INC

Comparable rows

0/10

Latest evidence

31 Dec 2022

3/4/5 13F Highest disclosed value: $100,885 10 rows are not safely comparable across share classes. Showing 1-6 of 10 holder rows.

Quick read

GOLDMAN SACHS GROUP INC has the largest disclosed position value at $100.9K.

0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GOLDMAN SACHS GROUP INC's linked filing trail.

Disclosed position value Top 2

GOLDMAN SACHS GROUP INC $100.9K

CSS LLC/IL $23K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 10 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Daniel J. O'Connor	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	— 1,558,302 shares mixed-class rows	—	12 Dec 2022
Larkspur Health LLC	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	— 1,377,599 shares mixed-class rows	—	06 Jan 2022
A.G.P. / ALLIANCE GLOBAL PARTNERS, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 446,843 shares	—	08 Mar 2022
GOLDMAN SACHS GROUP INC	13F Company 13F	— denominator unverified	$100,885 64,258 shares	—	31 Dec 2022
CSS LLC/IL	13F Company 13F	— denominator unverified	$22,997 14,648 shares	—	31 Dec 2022
David S. Briones	3/4/5 Chief Financial Officer, Director 3/4/5	— mixed-class rows	— 66,875 shares mixed-class rows	—	06 Jan 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

141,699

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %